Fifteen multi-factor patterns DeepVane screens the universe for every day. Each is grounded in published academic research, specifies which factor families must align for it to trigger, and shows how many tickers are currently matching.
134 tickers in the 234-name universe are matching one of these patterns right now. Click any pattern for a full explanation and a live ticker list.
Heavy short interest + the stock is rising + options flow is bullish. Short sellers are getting squeezed.
Strong earnings surprise + price confirmed by breaking out + quality is solid. The move has real earnings behind it.
High gross profitability + not expensive + clean accounting. The kind of business Buffett writes about.
Cheap after selloff + accounting looks clean + price action just stopped falling. Overreaction fading.
Top-quintile cheap + top-decile F-Score quality + momentum not collapsing. The classic Piotroski winner.
Earnings beat + price still rising afterward + sector also supportive + options flow bullish. Classic PEAD.
Strong momentum + solid quality, and the market regime says risk-on. Factor confluence riding a tailwind.
High quality + fair valuation + the market just went risk-off. The defensive basket that outperforms during stress.
A pharma ticker's Phase 3 trial reads as de-risked — failure probability well below the base rate.
Looks cheap but the business is broken: low quality, suspicious accruals, and a weak narrative tone. Classic value trap.
Expensive + strong momentum + shorts building + accruals deteriorating. Glamour stock about to mean-revert.
Reported quality still looks OK but accruals + momentum + narrative are all weakening. Early warning.
Extended price + expensive + nobody is short + options flow bearish. No margin of safety if anything goes wrong.
A pharma ticker's most urgent Phase 3 trial has a Bayesian failure probability well above the base rate.
Price is running but fundamentals (accruals, narrative, sector) aren't confirming. Divergence usually resolves against price.
A pharma ticker's Phase 3 trial hits its primary completion within 90 days. Binary event compresses the time window.
Factors are pointing in different directions — no coherent story. Confidence intervals widen; position-size accordingly.
No academic pattern fires and no single factor dominates. Score reflects the 12-factor weighted average.
Every ticker gets a straight 12-factor composite. On top of that, the confluence engine checks whether any of these patterns fires. When one does, its academic effect size overrides the straight composite — that's why you sometimes see a ticker with a score that doesn't match the simple weighted average of its factors.
For the math behind how overrides are weighted and how interval widths account for regime uncertainty, see the Methodology page.